Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | € 2.60M | € 600.00K | € 800.00K | € 2.50M | € 1.20M |
Total Assets | € 28.70M | € 26.00M | € 39.90M | € 40.40M | € 45.00M |
Total Debt | € 4.20M | € 6.80M | € 2.90M | € 1.90M | € 300.00K |
Net Debt | € 1.60M | € 6.20M | € 2.10M | € -600.00K | € -900.00K |
Total Liabilities | € 15.70M | € 21.60M | € 16.00M | € 16.20M | € 18.20M |
Stockholders Equity | € 13.00M | € 4.40M | € 23.90M | € 24.20M | € 26.90M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |